Updated Feb. 9, 2012 at 7:36 a.m.

Premium Lock Durham stem cell firm Aldagen sold for up to $40M

Published: 2012-02-09 06:43:00
Updated: 2012-02-09 07:36:00

A purified STEM cell A stem cell isolated, modified by Aldagen's technology. Image 1 of 2 · Next Image…

Regenerative medicine company Cytomedix has acquired the venture-capital backed company in a $16 million stock deal plus millions more in stock options. Aldagen investors include Intersouth and Aurora Funds....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll